Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors-Reference-Cited by-同舟云学术

Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors

Published:2024-06-11 Issue:7 Volume:21 Page:3502-3512
ISSN:1543-8384
Container-title:Molecular Pharmaceutics
language:en
Short-container-title:Mol. Pharmaceutics

Author:

Gao Feiyan¹,Ma Zhongyi¹,Luo Xing²,Wang Yahua¹,Liu Xinlong¹,Tang Mei¹,Chen Junyu¹,Tu Liangxing³,Ouyang Defang⁴,Zheng Ji²,Li Chong¹^ORCID

Affiliation:

1. Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China

2. Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, China

3. Division of Pharmaceutics, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China

4. State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China

Funder

Chongqing University

Chongqing Municipal Education Commission

Natural Science Foundation of Chongqing Municipality

Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.molpharmaceut.4c00204

Reference46 articles.

1. Cancer statistics, 2019

2. Prostate cancer: 4 big questions

3. Plant antitumor agents. VI. Isolation and structure of taxol, a novel antileukemic and antitumor agent from Taxus brevifolia

4. How Taxol/paclitaxel kills cancer cells

5. MicroRNA-624-mediated ARRDC3/YAP/HIF1α axis enhances esophageal squamous cell carcinoma cell resistance to cisplatin and paclitaxel